The U.S. Food and Drug Administration says drug makers have recalled more than a half-million bottles of the blood pressure medication prazosin hydrochloride over concerns it may include a cancer-causing chemical.
Related Articles
California museum’s collection looted: Over 1,000 items stolen in early morning heist
Advocates allege ‘inhumane’ conditions at Chicago-area ICE facility in new lawsuit
Refugees will be among the first to lose food stamps under federal changes
California faces limits as it directs health facilities to push back on immigration raids
Alaska Supreme Court weighs reinstating law that would require abortions be provided only by licensed physicians
New Jersey-based Teva Pharmaceuticals USA and drugs distributor Amerisource Health Services issued voluntary nationwide recalls earlier this month of more than 580,000 bottles of various strengths of prazosine capsules, according to the FDA.
Doctors prescribe prazosin, which relaxes blood vessels, to help lower blood pressure. It also is sometimes prescribed for nightmares and other sleep disturbances caused by post-traumatic stress disorder.
The FDA said in enforcement orders posted online that it has given the affected lots of the drug a Class II risk classification because some of the recalled medication may have nitrosamine impurities that are considered potentially cancer causing.
According to the FDA, N-nitrosamine impurities are a class of potentially cancer-causing chemicals that can form during manufacture or storage of a drug.
https://www.courant.com/2025/10/31/fda-recalls-blood-pressure-drug/

